Gordan Lauc, PhD
Glycobiology scientist whose IgG glycan research underpins GlycanAge's biological-age test
Practice
About
Gordan Lauc, PhD is GlycanAge's Co-Founder and Chief Scientific Officer and the scientist behind the IgG glycan biology the company commercializes. He is a University of Zagreb professor, founder and CEO of Genos Ltd., and co-director of the Human Glycome Project. His work connects IgG glycosylation patterns with chronic inflammation, immune aging, and biological-age estimation, giving GlycanAge its scientific foundation.
Approach
Signature approach
Lauc's role is methodology and scientific validation. His Zagreb group produced large-scale work on the plasma glycome, the human IgG glycome, and genetic drivers of glycosylation, with the 2014 Krištić et al. biological-age paper serving as a core bridge into GlycanAge's consumer test. At GlycanAge, that research becomes a practical assay for immune-aging trend tracking.
What sets them apart
- Deep glycomics record. Google Scholar listed roughly 21,000 citations, h-index 77, and i10-index 280 at capture.
- Genos founder. Genos developed the high-throughput IgG glycomics assay behind the product.
- Human Glycome Project leadership. Lauc initiated the project in 2017 and serves as one of its co-directors.
- Academic recognition. His public bios list Johns Hopkins Society of Scholars induction and visiting professorships at Johns Hopkins, University of Edinburgh, and Edith Cowan.
Training
Education
- PhD, BiochemistryUniversity of Zagreb (1995)
- MSc, Molecular BiologyUniversity of Zagreb (1992)
Published work
Publications
- Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 2014
- Immunoglobulin G glycosylation in aging and diseasesCellular Immunology, 2018
- Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological CancersPLOS Genetics, 2013
- High throughput isolation and glycosylation analysis of IgG — variability and heritability of the IgG glycome in three isolated human populationsMolecular & Cellular Proteomics, 2011
- Connecting genetic risk to disease end points through the human blood plasma proteomeNature Communications, 2017
- Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycansGlycobiology, 2010
Elsewhere
Media and talks
- YouTube (Gordan Lauc channel)
- Foresight Institute · 2021-06-14
- Expert Opinion on Therapeutic Targets (Taylor & Francis) · 2024
Collaboration
- Tim D. Spector, MDIgG glycomics co-research; King's College London / TwinsUK; fellow GlycanAge SAB member
- Vlatka Zoldoš, PhDEpigenetic regulation of glycosylation; University of Zagreb; fellow GlycanAge SAB member
- Manfred Wuhrer, PhDGlycomics analytics; Leiden University Medical Center
- Cristina Menni, PhDGlycan biological-age co-author (Krištić et al. 2014); King's College London
- Jim Wilson, PhDPopulation glycomics; University of Edinburgh, Usher Institute
Verification
- Profile updated
Primary sourcehttps://glycanage.com/about/our-team
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.